Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0IKWPY
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
RFT5-SMPT-dgA
|
|||||
| Synonyms |
Monoclonal antibody RFT5-ricin chain A conjugate; RFT5 ricin A; RFT5-dgA; RFT5-ricin A; RFT5ricin A
Click to Show/Hide
|
|||||
| Organization |
Koeln University, Texas University
|
|||||
| Drug Status |
Phase 1 (Terminated)
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
Undisclosed
|
|||||
| Antibody Name |
Anti-CD25 mAb RFT5
|
Antibody Info | ||||
| Antigen Name |
Interleukin-2 receptor subunit alpha (IL2RA)
|
Antigen Info | ||||
| Payload Name |
Deglycosylated ricin A-chain (dgA)
|
Payload Info | ||||
| Linker Name |
Succynimidyloxycarbonyl-alpha-methyl-alpha-(2-pyridyl-dithio) toluene (SMPT)
|
Linker Info | ||||
| Conjugate Type |
Undisclosed
|
|||||
